Durham Veterans Affairs Health Care System, Durham, North Carolina, USA.
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA.
J Dual Diagn. 2020 Oct;16(4):420-428. doi: 10.1080/15504263.2020.1797259. Epub 2020 Jul 31.
The objective of this study was to investigate the feasibility and acceptability of a multi-component mobile contingency management (CM) pilot intervention for smoking cessation for people with schizophrenia. This intervention included mobile CM (i.e., monetary compensation for bioverification of abstinence through using a phone app), cognitive behavioral therapy (CBT), and pharmacotherapy for smoking cessation. This intervention was compared to an intensive treatment comparison (ITC), which contained all components except the CM. Participants were bioverified with carbon monoxide and saliva cotinine at a 6-month follow-up session. In this pilot, the treatment group did not differ from the ITC at any time point. However, measures of treatment feasibility and acceptability indicated that smokers with schizophrenia were able to navigate the CM phone application and adhere to the protocol, demonstrating the potential utility of mobile interventions in this population. Despite lack of long-term abstinence for participants, adherence to the mobile application intervention indicates the potential for future investigation of mobile smoking cessation treatments for people with schizophrenia.
本研究旨在探讨多组分移动应对管理（CM）戒烟试验干预在精神分裂症患者中的可行性和可接受性。该干预措施包括移动 CM（即，通过使用手机应用程序对戒烟进行生物验证来获得货币补偿）、认知行为疗法（CBT）和戒烟药物治疗。该干预措施与强化治疗比较（ITC）进行比较，后者包含除 CM 之外的所有成分。在 6 个月的随访中，参与者通过一氧化碳和唾液可替宁进行生物验证。在本试验中，治疗组在任何时间点均与 ITC 无差异。但是，治疗可行性和可接受性的措施表明，精神分裂症吸烟者能够使用 CM 手机应用程序并遵守协议，这表明移动干预措施在该人群中的潜在应用。尽管参与者没有长期戒烟，但对移动应用程序干预的坚持表明，未来有必要对精神分裂症患者的移动戒烟治疗进行研究。
